Review of FDA’s Implementation of the Drug Export Amendments of 1986

Issue Date: November 1, 1989
Issued by: Center for Veterinary Medicine
Topic(s): Compliance, Current Good Manufacturing Practice (CGMP)
Status: Final

Review of FDA’s Implementation of the Drug Export Amendments of 1986

This document summarized the basic requirements of the 1986 Amendments.

Download the Guidance Document

webmaster1989-11-01T00:00:00+00:00

ABOUT US

Avance Biosciences is a leading Contract Research Organization (CRO) and Contract Testing Organization (CTO) providing CGMP and GLP-compliant analytical and bioanalytical services to support drug development. From early discovery through clinical development and commercialization, we provide CGMP and GLP-compliant services tailored to your therapeutic modality and regulatory needs.